Atlas Trials

A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration

Clinical trial NCT00346957 · COMPLETED

Trial details

NCT number
NCT00346957
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
AMD
Start date
1999-04-01
Primary completion
2003-04-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.